文献速递系统性红斑狼疮

高敏心肌肌钙蛋白T与系统性红斑狼疮患者心血管事件(TROPOPLUS研究)

Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study).
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究基于PLUS随机双盲安慰剂对照多中心试验,分析442例无心血管事件史的SLE患者,中位随访110个月,发现29例(6.6%)发生至少一次心血管事件。多因素分析显示血脂异常、年龄和高敏心肌肌钙蛋白T(HS-cTnT)与心血管事件相关,HS-cTnT>4.27 ng/l使心血管事件风险增加2.7倍(HR 2.7,95%CI 1.3-5.6,P=0.0083)。

要点

  • HS-cTnT是首个与SLE患者新发心血管事件独立相关的生物标志物。
  • HS-cTnT>4.27 ng/l时心血管事件风险增加2.7倍(95%CI 1.3-5.6,P=0.0083)。
  • 血脂异常和年龄也与SLE患者心血管事件发生相关。

核心结论

  • 血清HS-cTnT是首个被识别为与SLE患者新发心血管事件独立相关的生物标志物。

研究设计与样本

  • 研究筛选了2007至2010年间纳入随机双盲安慰剂对照多中心PLUS试验的全部SLE患者。
  • 分析对象为纳入时无心血管事件史且随访期>20个月的患者,共442例(PLUS研究573例中)。
  • HS-cTnT采用电化学发光法检测PLUS纳入时采集的血清,主要结局为新发心血管事件。

主要发现

  • 442例患者中位随访110个月(四分位距99-120),29例(6.6%)发生至少一次心血管事件,发生中位时间67个月(四分位距31-91)。
  • 29例中6例发生超过一次心血管事件。
  • 多因素分析显示血脂异常、年龄和HS-cTnT与心血管事件发生相关。
  • Kaplan-Meier分析显示纳入时HS-cTnT>4.27 ng/l使SLE患者心血管事件风险增加2.7倍(HR 2.7,95%CI 1.3-5.6,P=0.0083)。

关键数值与推荐

  • HS-cTnT>4.27 ng/l为风险增高阈值,对应HR 2.7(95%CI 1.3-5.6,P=0.0083)。

临床怎么用

  • 对SLE患者可检测血清HS-cTnT以辅助心血管风险分层,尤其关注HS-cTnT>4.27 ng/l者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Identification of biological markers able to better stratify cardiovascular risks in SLE patients is needed. We aimed to determine whether serum cardiac troponin T (cTnT) levels measured with a highly sensitive assay [high sensitivity cTnT (HS-cTnT)] may predict cardiovascular events (CVEs) in SLE. METHOD: All SLE patients included between 2007 and 2010 in the randomized, double-blind, placebo-controlled, multicentre PLUS trial were screened. Patients with no past history of CVE at inclusion and a follow-up period of >20 months were analysed. HS-cTnT concentration was measured using the electrochemiluminescence method on serum collected at PLUS inclusion. The primary outcome was the incident CVE. Factors associated with the primary outcome were identified and multivariate analysis was performed. RESULTS: Overall, 442 SLE patients (of the 573 included in the PLUS study) were analysed for the primary outcome with a median follow up of 110 (interquartile range: 99-120) months. Among them, 29 (6.6%) experienced at least one CVE that occurred at a median of 67 (interquartile range: 31-91) months after inclusion. Six out of 29 patients had more than one CVE. In the multivariate analysis, dyslipidaemia, age and HS-cTnT were associated with the occurrence of CVE. Kaplan-Meier analysis showed that a concentration of HS-cTnT > 4.27 ng/l at inclusion increased by 2.7 [hazard ratio 2.7 (95% CI: 1.3, 5.6), P =0.0083] the risk of CVE in SLE. CONCLUSION: HS-cTnT measured in serum is the first identified biomarker independently associated with incident CVE in SLE patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Chezel J, Costedoat-Chalumeau N, Laouénan C, et al. Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study). Rheumatology (Oxford). 2021. PMID: 32901293. doi:10.1093/rheumatology/keaa434

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。